: 24856512  [PubMed - in process]179. J Heart Lung Transplant. 2014 Jun;33(6):555-64. doi:10.1016/j.healun.2014.04.010. Epub 2014 Apr 21.Sixth INTERMACS annual report: a 10,000-patient database.Kirklin JK(1), Naftel DC(2), Pagani FD(3), Kormos RL(4), Stevenson LW(5), BlumeED(6), Miller MA(7), Timothy Baldwin J(7), Young JB(8).Author information: (1)Department of Surgery, University of Alabama at Birmingham, Alabama.Electronic address: jkirklin@uab.edu. (2)Department of Surgery, University ofAlabama at Birmingham, Alabama. (3)Department of Surgery, University of Michigan,Ann Arbor, Michigan. (4)Department of Surgery, University of Pittsburgh MedicalCenter, Presbyterian University Hospital, Pittsburgh, Pennsylvania. (5)Departmentof Medicine, Brigham & Women's Hospital, Boston, Massachusetts. (6)Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts. (7)Division ofCardiovascular Diseases, Advanced Technologies and Surgery Branch, National HeartLung and Blood Institute, Bethesda, Maryland. (8)Department of Medicine,Cleveland Clinic Foundation Lerner College of Medicine, Cleveland, Ohio.The sixth annual report of the Interagency Registry for Mechanically AssistedCirculatory Support (INTERMACS) summarizes the first 8 years of patientenrollment. The analysis is based on data from >10,000 patients and updatesdemographics, survival, adverse events and risk factors. Among patients withcontinuous-flow pumps, actuarial survival continues to be 80% at 1 year and 70%at 2 years. The report features a comparison of two eras of continuous-flowdurable devices in the USA in terms of device strategy, patient profiles, adverseevent burden, survival and quality of life.Copyright Â© 2014 International Society for Heart and Lung Transplantation. Allrights reserved.